{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:11:02Z","timestamp":1782745862397,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001794","name":"Pediatric Brain Tumor Foundation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["RO1NS093079"],"award-info":[{"award-number":["RO1NS093079"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Segal Family Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s11060-017-2681-8","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T12:22:00Z","timestamp":1511439720000},"page":"475-484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model"],"prefix":"10.1007","volume":"136","author":[{"given":"Nundia","family":"Louis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl C.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles O.","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystof","family":"Bankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-7052","authenticated-orcid":false,"given":"Nalin","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"key":"2681_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2006","unstructured":"Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241\u2013248. \n                        https:\/\/doi.org\/10.1016\/S1470-2045(06)70615-5","journal-title":"Lancet Oncol"},{"key":"2681_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz P, Hoeman C, Rakopoulos P, Pajovic S, Letourneau L, Dzamba M, Morrison A, Lewis P, Bouffet E, Bartels U, Zuccaro J, Agnihotri S, Ryall S, Barszczyk M, Chornenkyy Y, Bourgey M, Bourque G, Montpetit A, Cordero F, Castelo-Branco P, Mangerel J, Tabori U, Ho KC, Huang A, Taylor KR, Mackay A, Bendel AE, Nazarian J, Fangusaro JR, Karajannis MA, Zagzag D, Foreman NK, Donson A, Hegert JV, Smith A, Chan J, Lafay-Cousin L, Dunn S, Hukin J, Dunham C, Scheinemann K, Michaud J, Zelcer S, Ramsay D, Cain J, Brennan C, Souweidane MM, Jones C, Allis CD, Brudno M, Becher O, Hawkins C (2014) Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 46:451\u2013456. \n                        https:\/\/doi.org\/10.1038\/ng.2936","journal-title":"Nat Genet"},{"key":"2681_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.clineuro.2016.01.007","volume":"142","author":"CR Goodwin","year":"2016","unstructured":"Goodwin CR, Xu R, Iyer R, Sankey EW, Liu A, Abu-Bonsrah N, Sarabia-Estrada R, Frazier JL, Sciubba DM, Jallo GI (2016) Local delivery methods of therapeutic agents in the treatment of diffuse intrinsic brainstem gliomas. Clin Neurol Neurosurg 142:120\u2013127. \n                        https:\/\/doi.org\/10.1016\/j.clineuro.2016.01.007","journal-title":"Clin Neurol Neurosurg"},{"key":"2681_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3171\/2008.11.PEDS08281","volume":"3","author":"JL Frazier","year":"2009","unstructured":"Frazier JL, Lee J, Thomale UW, Noggle JC, Cohen KJ, Jallo GI (2009) Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. J Neurosurg Pediatr 3:259\u2013269. \n                        https:\/\/doi.org\/10.3171\/2008.11.PEDS08281","journal-title":"J Neurosurg Pediatr"},{"key":"2681_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/14737175.14732016.11175939","volume":"16","author":"SJ Han","year":"2016","unstructured":"Han SJ, Bankiewicz K, Butowski NA, Larson PS, Aghi MK (2016) Interventional MRI-guided catheter placement and real time drug delivery to the central nervous system. Expert Rev Neurother 16:635\u2013639. \n                        https:\/\/doi.org\/10.1080\/14737175.14732016.11175939","journal-title":"Expert Rev Neurother"},{"key":"2681_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/neuonc\/nos305","volume":"15","author":"PY Chen","year":"2013","unstructured":"Chen PY, Ozawa T, Drummond DC, Kalra A, Fitzgerald JB, Kirpotin DB, Wei KC, Butowski N, Prados MD, Berger MS, Forsayeth JR, Bankiewicz K, James CD (2013) Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts. Neuro Oncol 15:189\u2013197. \n                        https:\/\/doi.org\/10.1093\/neuonc\/nos305","journal-title":"Neuro Oncol"},{"key":"2681_CR7","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3171\/jns.2004.101.6.1004","volume":"101","author":"K Kawakami","year":"2004","unstructured":"Kawakami K, Kawakami M, Kioi M, Husain SR, Puri RK (2004) Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model. J Neurosurg 101:1004\u20131011. \n                        https:\/\/doi.org\/10.3171\/jns.2004.101.6.1004","journal-title":"J Neurosurg"},{"key":"2681_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1215\/15228517-2006-001","volume":"8","author":"R Saito","year":"2006","unstructured":"Saito R, Krauze MT, Noble CO, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS (2006) Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro Oncol 8:205\u2013214. \n                        https:\/\/doi.org\/10.1215\/15228517-2006-001","journal-title":"Neuro Oncol"},{"key":"2681_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.nurt.2007.10.064","volume":"5","author":"MS Fiandaca","year":"2008","unstructured":"Fiandaca MS, Forsayeth JR, Dickinson PJ, Bankiewicz KS (2008) Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics 5:123\u2013127. \n                        https:\/\/doi.org\/10.1016\/j.nurt.2007.10.064","journal-title":"Neurotherapeutics"},{"key":"2681_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3171\/2016.1.jns151591","volume":"126","author":"A Jahangiri","year":"2017","unstructured":"Jahangiri A, Chin AT, Flanigan PM, Chen R, Bankiewicz K, Aghi MK (2017) Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies. J Neurosurg 126:191\u2013200. \n                        https:\/\/doi.org\/10.3171\/2016.1.jns151591","journal-title":"J Neurosurg"},{"key":"2681_CR11","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.2217\/nnm.13.201","volume":"9","author":"CO Noble","year":"2014","unstructured":"Noble CO, Krauze MT, Drummond DC, Forsayeth J, Hayes ME, Beyer J, Hadaczek P, Berger MS, Kirpotin DB, Bankiewicz KS, Park JW (2014) Pharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumors. Nanomedicine 9:2099\u20132108. \n                        https:\/\/doi.org\/10.2217\/nnm.13.201","journal-title":"Nanomedicine"},{"key":"2681_CR12","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1158\/0008-5472.can-05-3535","volume":"66","author":"CO Noble","year":"2006","unstructured":"Noble CO, Krauze MT, Drummond DC, Yamashita Y, Saito R, Berger MS, Kirpotin DB, Bankiewicz KS, Park JW (2006) Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Res 66:2801\u20132806. \n                        https:\/\/doi.org\/10.1158\/0008-5472.can-05-3535","journal-title":"Cancer Res"},{"key":"2681_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1215\/15228517-2008-075","volume":"11","author":"JJ Vredenburgh","year":"2009","unstructured":"Vredenburgh JJ, Desjardins A, Reardon DA, Friedman HS (2009) Experience with irinotecan for the treatment of malignant glioma. Neuro Oncol 11:80\u201391. \n                        https:\/\/doi.org\/10.1215\/15228517-2008-075","journal-title":"Neuro Oncol"},{"key":"2681_CR14","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1158\/0008-5472.can-05-4007","volume":"66","author":"DC Drummond","year":"2006","unstructured":"Drummond DC, Noble CO, Guo Z, Hong K, Park JW, Kirpotin DB (2006) Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy. Cancer Res 66:3271\u20133277. \n                        https:\/\/doi.org\/10.1158\/0008-5472.can-05-4007","journal-title":"Cancer Res"},{"key":"2681_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/s0140-6736(15)00986-1","volume":"387","author":"A Wang-Gillam","year":"2016","unstructured":"Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, Jameson G, Macarulla T, Lee KH, Cunningham D, Blanc JF, Hubner RA, Chiu CF, Schwartsmann G, Siveke JT, Braiteh F, Moyo V, Belanger B, Dhindsa N, Bayever E, Von Hoff DD, Chen LT (2016) Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet 387:545\u2013557. \n                        https:\/\/doi.org\/10.1016\/s0140-6736(15)00986-1","journal-title":"Lancet"},{"key":"2681_CR16","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria SV, Hanson LR, Frey WH 2nd (2010) Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99:1654\u20131673 \n                        https:\/\/doi.org\/10.1002\/jps.21924","journal-title":"J Pharm Sci"},{"key":"2681_CR17","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1021\/mp900275s","volume":"7","author":"T Shingaki","year":"2010","unstructured":"Shingaki T, Inoue D, Furubayashi T, Sakane T, Katsumi H, Yamamoto A, Yamashita S (2010) Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy. Mol Pharm 7:1561\u20131568. \n                        https:\/\/doi.org\/10.1021\/mp900275s","journal-title":"Mol Pharm"},{"key":"2681_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/10611869909085506","volume":"7","author":"T Sakane","year":"1999","unstructured":"Sakane T, Yamashita S, Yata N, Sezaki H (1999) Transnasal delivery of 5-fluorouracil to the brain in the rat. J Drug Target 7:233\u2013240. \n                        https:\/\/doi.org\/10.3109\/10611869909085506","journal-title":"J Drug Target"},{"key":"2681_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00280-005-0018-3","volume":"57","author":"D Wang","year":"2006","unstructured":"Wang D, Gao Y, Yun L (2006) Study on brain targeting of raltitrexed following intranasal administration in rats. Cancer Chemother Pharmacol 57:97\u2013104. \n                        https:\/\/doi.org\/10.1007\/s00280-005-0018-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"2681_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11060-009-9954-9","volume":"96","author":"R Hashizume","year":"2010","unstructured":"Hashizume R, Ozawa T, Dinca EB, Banerjee A, Prados MD, James CD, Gupta N (2010) A human brainstem glioma xenograft model enabled for bioluminescence imaging. J Neurooncol 96:151\u2013159. \n                        https:\/\/doi.org\/10.1007\/s11060-009-9954-9","journal-title":"J Neurooncol"},{"key":"2681_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3171\/JNS-07\/09\/0610","volume":"107","author":"EB Dinca","year":"2007","unstructured":"Dinca EB, Sarkaria JN, Schroeder MA, Carlson BL, Voicu R, Gupta N, Berger MS, James CD (2007) Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy. J Neurosurg 107:610\u2013616. \n                        https:\/\/doi.org\/10.3171\/JNS-07\/09\/0610","journal-title":"J Neurosurg"},{"key":"2681_CR22","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/1535-7163.mct-06-0691","volume":"6","author":"JN Sarkaria","year":"2007","unstructured":"Sarkaria JN, Yang L, Grogan PT, Kitange GJ, Carlson BL, Schroeder MA, Galanis E, Giannini C, Wu W, Dinca EB, James CD (2007) Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel. Mol Cancer Ther 6:1167\u20131174. \n                        https:\/\/doi.org\/10.1158\/1535-7163.mct-06-0691","journal-title":"Mol Cancer Ther"},{"key":"2681_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1215\/15228517-2007-052","volume":"10","author":"R Hashizume","year":"2008","unstructured":"Hashizume R, Ozawa T, Gryaznov SM, Bollen AW, Lamborn KR, Frey WH 2nd, Deen DF (2008) New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163. Neuro Oncol 10:112\u2013120 \n                        https:\/\/doi.org\/10.1215\/15228517-2007-052","journal-title":"Neuro Oncol"},{"key":"2681_CR24","doi-asserted-by":"publisher","DOI":"10.3791\/1992","author":"L Serwer","year":"2010","unstructured":"Serwer L, Hashizume R, Ozawa T, James CD (2010) Systemic and local drug delivery for treating diseases of the central nervous system in rodent models. J Vis Exp. \n                        https:\/\/doi.org\/10.3791\/1992","journal-title":"J Vis Exp"},{"key":"2681_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11060-012-0973-6","volume":"110","author":"R Hashizume","year":"2012","unstructured":"Hashizume R, Smirnov I, Liu S et al (2012) Characterization of a diffuse intrinsic pontine cell line: implications for future investigations and treatment. J Neurooncol 110:305\u2013313. \n                        https:\/\/doi.org\/10.1007\/s11060-012-0973-6","journal-title":"J Neurooncol"},{"key":"2681_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11060-011-0796-x","volume":"108","author":"Y Aoki","year":"2012","unstructured":"Aoki Y, Hashizume R, Ozawa T, Banerjee A, Prados M, James CD, Gupta N (2012) An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing. J Neurooncol 108:29\u201335. \n                        https:\/\/doi.org\/10.1007\/s11060-011-0796-x","journal-title":"J Neurooncol"},{"key":"2681_CR27","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.3716","volume":"20","author":"R Hashizume","year":"2014","unstructured":"Hashizume R, Andor N, Ihara Y, Lerner R, Gan H, Chen X, Fang D, Huang X, Tom MW, Ngo V, Solomon D, Mueller S, Paris PL, Zhang Z, Petritsch C, Gupta N, Waldman TA, James CD (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20:1394\u20131396. \n                        https:\/\/doi.org\/10.1038\/nm.3716","journal-title":"Nat Med"},{"key":"2681_CR28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/neuonc\/nop054","volume":"12","author":"S Kunwar","year":"2010","unstructured":"Kunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, Shaffrey M, Ram Z, Piepmeier J, Prados M, Croteau D, Pedain C, Leland P, Husain SR, Joshi BH, Puri RK (2010) Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol 12:871\u2013881. \n                        https:\/\/doi.org\/10.1093\/neuonc\/nop054","journal-title":"Neuro Oncol"},{"key":"2681_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejpb.2006.05.005","volume":"64","author":"M Tafaghodi","year":"2006","unstructured":"Tafaghodi M, Jaafari MR, Tabassi SAJ (2006) Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN. Eur J Pharm Biopharm 64:138\u2013145 \n                        https:\/\/doi.org\/10.1016\/j.ejpb.2006.05.005","journal-title":"Eur J Pharm Biopharm"},{"key":"2681_CR30","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.peptides.2009.03.018","volume":"30","author":"M Chen","year":"2009","unstructured":"Chen M, Li XR, Zhou YX, Yang KW, Chen XW, Deng Q, Liu Y, Ren LJ (2009) Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery. Peptides 30:1288\u20131295. \n                        https:\/\/doi.org\/10.1016\/j.peptides.2009.03.018","journal-title":"Peptides"},{"key":"2681_CR31","unstructured":"University of California in San Francisco. CED with irinotecan liposome injection using real time imaging in children with DIPG. \n                        https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03086616\n                        \n                    . NML Identifier: NCT03086616. Accessed 14 June 2017"},{"key":"2681_CR32","first-page":"2573","volume":"164","author":"R Saito","year":"2004","unstructured":"Saito R, Bringas J, McKnight TR, Wendland MF, Manot C, Drummond DC, Kirpotin DB, Park JW, Berger MS, Bankiewiez KS (2004) Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res 164:2573\u20132579","journal-title":"Cancer Res"},{"key":"2681_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainresprot.2005.08.003","volume":"16","author":"MT Krauze","year":"2005","unstructured":"Krauze MT, McKnight TR, Yamashita Y, Bringas J, Noble CO, Saito R, Geletneky K, Forsayeth J, Berger MS, Jackson P, Park JW, Bankiewicz KS (2005) Real time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Res Brain Res Protoc 16:20\u201326. \n                        https:\/\/doi.org\/10.1016\/j.brainresprot.2005.08.003","journal-title":"Brain Res Brain Res Protoc"},{"key":"2681_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.expneurol.2005.08.016","volume":"196","author":"R Saito","year":"2005","unstructured":"Saito R, Krauze MT, Bringas JR, Noble C, McKnight TR, Jackson P, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Hong K, Berger MS, Park JW, Bankiewicz KS (2005) Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp Neurol 196:381\u2013389. \n                        https:\/\/doi.org\/10.1016\/j.expneurol.2005.08.016","journal-title":"Exp Neurol"},{"key":"2681_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou206.46","author":"N Butowski","year":"2014","unstructured":"Butowski N, Bankiewicz K, Kells A et al (2014) A phase I study of convection-enhanced delivery of liposomal-irinotecan using real-time imaging with gadolinium in patients with recurrent high grade glioma. Neuro-Oncology. \n                        https:\/\/doi.org\/10.1093\/neuonc\/nou206.46","journal-title":"Neuro-Oncology"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2681-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T12:33:57Z","timestamp":1518093237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2681-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,23]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2681"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2681-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,23]]}}}